title: Investigating the Release of a Hydrophobic Peptide from Matrices of Biodegradable Polymers: An Integrated Method Approach.
abstract: The objectives of this work were: (1) to select suitable compositions of tyrosine-derived polycarbonates for controlled delivery of voclosporin, a potent drug candidate to treat ocular diseases, (2) to establish a structure-function relationship between key molecular characteristics of biodegradable polymer matrices and drug release kinetics, and (3) to identify factors contributing in the rate of drug release. For the first time, the experimental study of polymeric drug release was accompanied by a hierarchical sequence of three computational methods. First, suitable polymer compositions used in subsequent neural network modeling were determined by means of response surface methodology (RSM). Second, accurate artificial neural network (ANN) models were built to predict drug release profiles for fifteen polymers located outside the initial design space. Finally, thermodynamic properties and hydrogen-bonding patterns of model drug-polymer complexes were studied using molecular dynamics (MD) technique to elucidate a role of specific interactions in drug release mechanism. This research presents further development of methodological approaches to meet challenges in the design of polymeric drug delivery systems.
authors.affiliation: New Jersey Center for Biomaterials, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8087, USA.
authors.forename: Anna V
authors.initials: AV
authors.lastname: Gubskaya
authors.forename: I John
authors.initials: IJ
authors.lastname: Khan
authors.forename: Loreto M
authors.initials: LM
authors.lastname: Valenzuela
authors.forename: Yuriy V
authors.initials: YV
authors.lastname: Lisnyak
authors.forename: Joachim
authors.initials: J
authors.lastname: Kohn
keywords: computational modeling; hydrogen bonding; hydrophobic peptide; polymeric drug release; structure-function relationship
references.citation: Int J Pharm. 2011 Aug 30;415(1-2):34-52
references.pmid: 21640806
references.citation: Anal Chem. 2005 Aug 15;77(16):5196-204
references.pmid: 16097759
references.citation: Drug Dev Ind Pharm. 2011 Feb;37(2):167-77
references.pmid: 21073319
references.citation: Acta Biomater. 2010 Apr;6(4):1370-9
references.pmid: 19900594
references.citation: Biomaterials. 1999 Feb;20(3):253-64
references.pmid: 10030602
references.citation: Adv Drug Deliv Rev. 2003 Apr 25;55(4):447-66
references.pmid: 12706045
references.citation: Polymer (Guildf). 2007 Sep 10;48(19):5788-5801
references.pmid: 19568328
references.citation: J Phys Chem B. 2009 Nov 19;113(46):15181-8
references.pmid: 19856949
references.citation: Acta Crystallogr D Biol Crystallogr. 2009 Nov;65(Pt 11):1187-95
references.pmid: 19923714
references.citation: Drug Dev Ind Pharm. 2010 Nov;36(11):1377-87
references.pmid: 20545520
references.citation: Eur J Pharm Sci. 2007 Jul;31(3-4):202-10
references.pmid: 17482436
references.citation: Transpl Int. 2005 May;17(12):767-71
references.pmid: 15827754
references.citation: Drug Discov Today. 2008 Feb;13(3-4):135-43
references.pmid: 18275911
references.citation: Biomacromolecules. 2008 Nov;9(11):3014-23
references.pmid: 18937398
references.citation: J Mol Biol. 1994 Dec 9;244(4):385-409
references.pmid: 7990129
references.citation: Eur J Pharm Sci. 2005 Apr;24(5):401-10
references.pmid: 15784330
references.citation: Expert Opin Drug Deliv. 2010 Apr;7(4):429-44
references.pmid: 20331353
references.citation: Drug Dev Ind Pharm. 2011 Apr;37(4):465-74
references.pmid: 21446831
references.citation: Macromol Theory Simul. 2011 May 23;20(4):275-285
references.pmid: 25663794
references.citation: Chem Soc Rev. 2008 Aug;37(8):1473-81
references.pmid: 18648673
references.citation: J Biomed Mater Res A. 2009 Mar 15;88(4):976-89
references.pmid: 18384171
references.citation: Chem Pharm Bull (Tokyo). 2009 Sep;57(9):914-9
references.pmid: 19721251
references.citation: J Funct Biomater. 2012 Oct 30;3(4):745-59
references.pmid: 24955746
references.citation: Biophys J. 2007 Sep 15;93(6):2152-61
references.pmid: 17513360
references.citation: Phys Rev Lett. 2000 Dec 25;85(26 Pt 1):5583-6
references.pmid: 11136052
references.citation: J Pharm Sci. 2004 Feb;93(2):418-30
references.pmid: 14705198
references.citation: Expert Opin Investig Drugs. 2007 Oct;16(10):1525-40
references.pmid: 17922618
references.citation: J Chem Phys. 2008 Jun 14;128(22):225103
references.pmid: 18554060
references.citation: Adv Drug Deliv Rev. 2003 Sep 12;55(9):1201-15
references.pmid: 12954199
references.citation: J Control Release. 2003 Jul 31;90(3):291-301
references.pmid: 12880696
references.citation: Biomacromolecules. 2005 May-Jun;6(3):1239-51
references.pmid: 15877338
references.citation: Pharm Dev Technol. 2006;11(3):337-49
references.pmid: 16895844
references.citation: J Biomater Sci Polym Ed. 2006;17(9):1039-56
references.pmid: 17094641
references.citation: J Chem Inf Comput Sci. 2004 May-Jun;44(3):1088-97
references.pmid: 15154777
references.citation: Biomaterials. 1999 Feb;20(3):265-72
references.pmid: 10030603
references.citation: Eur Cell Mater. 2008 Apr 25;15:77-87
references.pmid: 18438755
references.citation: Nanomedicine. 2009 Dec;5(4):394-401
references.pmid: 19341814
references.citation: J Pharm Biomed Anal. 2003 Feb 5;31(1):159-68
references.pmid: 12560060
references.citation: J Mol Model. 2011 May;17(5):1141-7
references.pmid: 20686909